SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-002828
Filing Date
2024-03-08
Accepted
2024-03-08 17:00:32
Documents
61
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A tmb-20231231x10ka.htm   iXBRL 10-K/A 1344443
2 EX-31.3 tmb-20231231xex31d3.htm EX-31.3 14992
3 EX-31.4 tmb-20231231xex31d4.htm EX-31.4 14775
4 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 10388
5 GRAPHIC tmb-20231231x10ka001.jpg GRAPHIC 89105
6 GRAPHIC tmb-20231231x10ka002.jpg GRAPHIC 34691
7 GRAPHIC tmb-20231231x10ka003.jpg GRAPHIC 11340
8 GRAPHIC tmb-20231231x10ka004.jpg GRAPHIC 27928
  Complete submission text file 0001558370-24-002828.txt   5394202

Data Files

Seq Description Document Type Size
9 EX-101.SCH tmb-20231231.xsd EX-101.SCH 34887
10 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 33029
11 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 140517
12 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 336105
13 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 259465
63 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10ka_htm.xml XML 554606
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39811 | Film No.: 24735333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)